Macrophage colony-stimulating factor enhances rituximab-dependent cellular cytotoxicity by monocytes-Reference-Cited by-同舟云学术

Macrophage colony-stimulating factor enhances rituximab-dependent cellular cytotoxicity by monocytes

Published:2007-09 Issue:9 Volume:98 Page:1368-1372
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Shimadoi Shigeru,Takami Akiyoshi,Kondo Yukio,Okumura Hirokazu,Nakao Shinji

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2007.00544.x/fullpdf

Reference35 articles.

1. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study;Coiffier;Blood,1998

2. Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma;Hainsworth;Blood,2000

3. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program;McLaughlin;J Clin Oncol,1998

4. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia;Sehn;J Clin Oncol,2005

5. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of central nervous system lymphoma in rats with intraventricular rituximab and serum;International Journal of Hematology;2010-09-07

2. Tumor Microenvironment and Immune Effects of Antineoplastic Therapy in Lymphoproliferative Syndromes;Journal of Biomedicine and Biotechnology;2010

3. Strategies to enhance rituximab anti-tumor activity in the treatment of CD20-positive B-cell neoplasms;Immunologic Research;2009-09-11

4. The Role of Complement in the Mechanism of Action of Rituximab for B-Cell Lymphoma: Implications for Therapy;The Oncologist;2008-09-01